Table 5.

Proportion of times that a drug-class ended up among the top three (in repeated simulations)

	Mortality	Myocardial infarction	Stroke	Angina	Heart failure	Diabetes
Diuretics	18%	79%	46%	33%	99%	1%
BB	1%	2%	3%	38%	10%	9%
ACE	23%	75%	11%	27%	83%	96%
CCB	54%	36%	98%	51%	1%	62%
Alpha-blocker	25%	58%	9%	45%	0%	-
ARB	49%	5%	60%	22%	22%	99%
Diuretics and/or BB	84%	45%	71%	22%	65%	33%
"Conventional"	46%	0%	1%	-	20%	-

ACE, Angiotensin Converting Enzyme Inhibitors; ARB, Angiotensin Receptor Blockers; BB, Beta-blockers; CCB, Calcium Channel Blockers;